Statistics for Análise económica do rituximab, em associação com ciclofosfamida, vincristina e prednisolona no tratamento de doentes com linfoma folicular avançado em Portugal
Total visits
| views | |
|---|---|
| Análise económica do rituximab, em associação com ciclofosfamida, vincristina e prednisolona no tratamento de doentes com linfoma folicular avançado em Portugal | 431 |
Total visits per month
| views | |
|---|---|
| July 2024 | 1 |
| August 2024 | 1 |
| September 2024 | 0 |
| October 2024 | 16 |
| November 2024 | 7 |
| December 2024 | 7 |
| January 2025 | 0 |
File Visits
| views | |
|---|---|
| AMP Rituximab.pdf(legacy) | 768 |
Top country views
| views | |
|---|---|
| Brazil | 201 |
| United States | 79 |
| Portugal | 57 |
| China | 19 |
| Germany | 14 |
| France | 12 |
| Canada | 11 |
| Angola | 4 |
| Netherlands | 4 |
| Australia | 3 |
| Spain | 2 |
| Italy | 2 |
| Romania | 2 |
| Argentina | 1 |
| Curaçao | 1 |
| European Union | 1 |
| United Kingdom | 1 |
| Hong Kong SAR China | 1 |
| Ireland | 1 |
| India | 1 |
| Japan | 1 |
| Peru | 1 |
| Russia | 1 |
| Ukraine | 1 |